Assisting vaccine candidates from SMEs and venture companies in entering the non-clinical and clinical stages by establishing a contract development manufacturing organization (CDMO) for international level vaccine production

Supporting specialized vaccine contract manufacturing and expansion to the global stage for venture companies and SMEs facing challenges in acquiring expensive vaccine production facilities